These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38237316)

  • 1. Purified cannabidiol as add-on therapy in children with treatment-resistant infantile epileptic spasms syndrome.
    Reyes Valenzuela G; Gallo A; Calvo A; Chacón S; Fasulo L; Galicchio S; Adi J; Fortini PS; Caraballo R
    Seizure; 2024 Feb; 115():94-99. PubMed ID: 38237316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol-enriched medical cannabis as add-on therapy in children with treatment-resistant West syndrome: A study of eight patients.
    Caraballo R; Valenzuela GR
    Seizure; 2021 Nov; 92():238-243. PubMed ID: 34624613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Response, Long-Term Seizure Outcome, and Very-Low-Dose Adrenocorticotrophic Hormone Therapy for Infantile Epileptic Spasms Syndrome With Down Syndrome.
    Hirata Y; Hamano SI; Hirano D; Matsuura R; Koichihara R; Takeda R; Takeuchi H; Kikuchi K
    Pediatr Neurol; 2024 Jul; 156():191-197. PubMed ID: 38795573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol in treatment of refractory epileptic spasms: An open-label study.
    Herlopian A; Hess EJ; Barnett J; Geffrey AL; Pollack SF; Skirvin L; Bruno P; Sourbron J; Thiele EA
    Epilepsy Behav; 2020 May; 106():106988. PubMed ID: 32169600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term analysis of adrenocorticotropic hormone monotherapy for infantile epileptic spasms syndrome with periventricular leukomalacia.
    Matsuura R; Hamano SI; Hirata Y; Takeda R; Takeuchi H; Koichihara R; Kikuchi K; Oka A
    Seizure; 2023 Jul; 109():40-44. PubMed ID: 37207538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy.
    Marchese F; Vari MS; Balagura G; Riva A; Salpietro V; Verrotti A; Citraro R; Lattanzi S; Minetti C; Russo E; Striano P
    Cannabis Cannabinoid Res; 2022 Apr; 7(2):199-206. PubMed ID: 33998856
    [No Abstract]   [Full Text] [Related]  

  • 8. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
    Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A;
    Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
    Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
    CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Landscape of genetic infantile epileptic spasms syndrome-A multicenter cohort of 124 children from India.
    Nagarajan B; Gowda VK; Yoganathan S; Sharawat IK; Srivastava K; Vora N; Badheka R; Danda S; Kalane U; Kaur A; Madaan P; Mehta S; Negi S; Panda PK; Rajadhyaksha S; Saini AG; Saini L; Shah S; Srinivasan VM; Suthar R; Thomas M; Vyas S; Sankhyan N; Sahu JK
    Epilepsia Open; 2023 Dec; 8(4):1383-1404. PubMed ID: 37583270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epileptic spasms in tuberous sclerosis complex.
    Hsieh DT; Jennesson MM; Thiele EA
    Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of epileptic spasms: A study of 21 children.
    Caraballo R; Semprino M; Fasulo L; Reyes G; Chacón S; Gallo A; Buompadre C
    Epilepsy Behav; 2022 Jan; 126():108451. PubMed ID: 34864379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional vitamin B12 deficiency-associated Infantile epileptic spasms syndrome: Clinico-neurophysiological presentation, response to treatment, and neurodevelopmental outcome.
    Sharawat IK; Ramachandran A; Elwadhi A; Tomar A; Panda PK
    Seizure; 2023 Aug; 110():93-98. PubMed ID: 37331199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy.
    Pietrafusa N; Ferretti A; Trivisano M; de Palma L; Calabrese C; Carfì Pavia G; Tondo I; Cappelletti S; Vigevano F; Specchio N
    Paediatr Drugs; 2019 Aug; 21(4):283-290. PubMed ID: 31179531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifteen years of real-world data on the use of vigabatrin in individuals with infantile epileptic spasms syndrome.
    Kuchenbuch M; Lo Barco T; Chemaly N; Chiron C; Nabbout R
    Epilepsia; 2024 Feb; 65(2):430-444. PubMed ID: 37872396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic pharmaceutical grade cannabidiol for treatment of refractory infantile spasms: A multicenter phase-2 study.
    Hussain SA; Dlugos DJ; Cilio MR; Parikh N; Oh A; Sankar R
    Epilepsy Behav; 2020 Jan; 102():106826. PubMed ID: 31816477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epileptic spasms relapse is associated with response latency but not conventional attributes of post-treatment EEG.
    Deckard E; Sathe R; Tabibzadeh D; Terango A; Groves A; Rajaraman RR; Nariai H; Hussain SA
    Epilepsia Open; 2024 Jun; 9(3):1034-1041. PubMed ID: 38588009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and safety of cannabidiol (CBD) in children with treatment-resistant epilepsy: Results from a state-based expanded access program.
    Park YD; Linder DF; Pope J; Flamini JR; Moretz K; Diamond MP; Long SA
    Epilepsy Behav; 2020 Nov; 112():107474. PubMed ID: 33181893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing the clinical onset of epileptic spasms in infantile epileptic spasms syndrome: A tertiary health center's experience.
    Hadjinicolaou A; Briscoe Abath C; Singh A; Donatelli S; Salussolia CL; Cohen AL; He J; Gupta N; Merchant S; Zhang B; Olson H; Yuskaitis CJ; Libenson MH; Harini C
    Epilepsia; 2024 Apr; 65(4):984-994. PubMed ID: 38317356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.